PortiVix is built for the way pharma teams actually make decisions.
Different teams need different views of the same truth. PortiVix gives leadership, PMO, project managers, R&D, regulatory, finance, supply chain, and IT the context they need without forcing everyone into the same dashboard.
CXO / Head of R&D
Fewer surprises before portfolio reviews.
What you deal with today
You need to know which assets are moving, which are stuck, where capital is exposed, and what needs intervention before the next review.
What changes with PortiVix
A live leadership view of pipeline health, risk, financial value, and execution readiness before decisions are due.
Relevant reports & views
PMO Leads
Stop compiling. Start governing.
What you deal with today
Your team spends days rebuilding the same status pack from emails, spreadsheets, and calls.
What changes with PortiVix
Live governance visibility and named accountability across programmes and projects - replacing weekly pack reconstruction.
Relevant reports & views
Portfolio Managers
Your pipeline, without the briefing pack.
What you deal with today
You need molecule, commercial, risk, phase, financial, and decision history together - especially when leadership asks, “What changed?”
What changes with PortiVix
Molecule record, phase gates, risk scores, NPV/eNPV, snapshots, baselines, and re-baseline history in one place.
Relevant reports & views
Project Managers
Every task owned. Every deadline visible. No chasing.
What you deal with today
You manage cross-functional execution and should not discover a delay after it has already affected a milestone.
What changes with PortiVix
Governed project plans from milestone to activity, with dependencies, approvals, risks, issues, comments, and documents.
Relevant reports & views
Regulatory Affairs & QA
Evidence that exists before you need it.
What you deal with today
Audit and inspection readiness should not begin with searching email threads and folders.
What changes with PortiVix
Approval, phase, change, and audit evidence stay connected to the work - ready before an inspection, not rebuilt during one.
Relevant reports & views
Finance Leaders & Analysts
Portfolio value, adjusted for probability and risk.
What you deal with today
Capital decisions need more than status - you need value, probability, actuals, and risk in one context.
What changes with PortiVix
NPV/eNPV, probability of success, actuals, and risk indicators connected to each molecule for risk-adjusted prioritisation.
Relevant reports & views
Supply Chain & Materials Teams
Material readiness visible before it becomes a launch risk.
What you deal with today
Material composition, vendor readiness, lead time, and sourcing exposure need to be part of the operating view.
What changes with PortiVix
Stage-wise quantities, vendor records, lead times, country of origin, budgets, and version history - connected to the molecule.
Relevant reports & views
Scientists & R&D Teams
Less status chasing. More accountable scientific work.
What you deal with today
You need a simple way to update molecule progress, tasks, risks, documents, and comments without losing scientific context.
What changes with PortiVix
Molecule profile, phase tasks, PTRS/IP risk inputs, comments, documents, approvals, and snapshots in one governed place.
Relevant reports & views
IT & Tenant Admins
One access model. One audit trail. One configurable platform.
What you deal with today
You need secure deployment, identity integration, tenant configuration, feature flags, and reliable audit controls - without fragmented tools.
What changes with PortiVix
Cloud hosting, SSO, MFA, capability-level RBAC, project access rules, tenant settings, feature flags, and an exportable audit log.
Relevant reports & views
See your team's view, mapped to your workflows.
We do not start with a generic demo. We map your portfolio, molecule, project, approval, reporting, and governance workflows first - then show how PortiVix would work for your organisation.